The symposium aims to tighten the relationship between EPFL and Idorsia, a Basel based biopharmaceutical company specialized in the discovery and development of small molecules to provide innovative therapeutic possibilities.
Presentations and discussions will explore potential research and students collaborations.
This is a unique opportunity to exchange with actors from industry, scientists and students interested in biopharmaceutical developments are encouraged to attend.